Year: 2026
Type: article
Abstract: The hippocampus is one of the earliest and most severely affected brain regions in Alzheimer’s disease (AD) and is critical for memory formation. However, the precise mechanisms through which AD disrupts hippocampal neurons remain poorly understood. To investigate the effects of Aβ42 in a model closer to humans, we performed stereotaxic injections of an AAV9 vector encoding human Aβ42 into the hippocampus of young (7-year-old) and aged (>20-year-old) cynomolgus monkeys. We found that AAV9-mediated Aβ42 expression induced more severe neuropathology, reduced daytime activity, and increased sleep disturbances in aged monkeys compared to young controls. snRNA-seq revealed an age-dependent reduction in disease-associated microglia (DAM II) in the aged hippocampus. Furthermore, we identified a specific subtype of hippocampal pyramidal neuron (TRPS1+RELN+) that is selectively vulnerable to Aβ42 toxicity in aged monkeys. Our findings indicate that Aβ42 toxicity is exacerbated in the aged primate hippocampus due to a combination of microglial decline and the selective vulnerability of a distinct neuronal subtype (TRPS1⁺RELN⁺ PCs). This identified subtype represents a new potential therapeutic target for treating hippocampal dysfunction in AD.
Source: 动物学研究
Authors: Chen Laiqiang, 暨南大学附属第一医院神经外科, 广东 广州 510630, 中国, Wang Zhifu, Ma Yu-Heng, Lin Yingqi, Song Xichen, Luo Xiaopeng, Chen Kecheng, Wang Lu, Xu Hao, Li Shihua, Yan Sen, Wang Xiangyu, Wen Jun, Yang Weili, Li Bang, Li Xiao-Jiang, 暨南大学粤港澳中枢神经再生研究院, 广东省非人灵长类动物模型研究重点实验室, 广东 广州 510632, 中国, 深圳市人民医院神经内科,暨南大学第二临床医学院,广东 深圳 518020,中国, 生物活性分子与成药性评估全国重点实验室, 广东 广州 510632, 中国, 暨南大学附属第一医院核医学科与PET/CT-MRI中心, 回旋加速器与PET放射性药物中心, 广东 广州 510630, 中国, 铜仁学院农林工程与规划学院, 贵州 铜仁 554300, 中国, 临港实验室, 上海 201306, 中国
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7160821048
